Skip to main content
ASSURE TECH (HANGZHOU) CO., LTD. logo

ASSURE TECH (HANGZHOU) CO., LTD. — Investor Relations & Filings

Ticker · 688075 ISIN · CNE100004ZC0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2025-08-06 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688075

About ASSURE TECH (HANGZHOU) CO., LTD.

https://www.diareagent.com/

Assure Tech (Hangzhou) Co., Ltd. is a biotechnology enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and clinical testing instruments. The company focuses on rapid diagnostic tests and Point of Care Testing (POCT) solutions across various medical fields, including infectious diseases, drug of abuse screening, oncology, cardiac markers, and fertility. Utilizing advanced lateral flow immunoassay technology, Assure Tech provides diagnostic tools designed for accuracy and efficiency in clinical and laboratory settings. The company adheres to international quality standards, maintaining ISO 13485 certification and obtaining regulatory clearances such as FDA and CE marks for its product range. Through its integrated R&D and production infrastructure, Assure Tech supplies a diverse portfolio of diagnostic products to a global customer base.

Recent filings

Filing Released Lang Actions
董事会议事规则（202508）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors'. It details the composition, responsibilities, meeting procedures, voting rules, and other governance-related aspects of the company's board. There is no financial data, no mention of financial results, no audit opinions, no shareholder voting results, no capital changes, no legal proceedings, and no earnings information. The content is focused on internal governance structure and board operation rules, which aligns with governance information filings. The document is lengthy (6828 characters) and is a full set of rules, not an announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2025-08-06 Chinese
信息披露管理制度（202508）
Governance Information Classification · 95% confidence The document is a comprehensive information disclosure management system of a company, detailing the principles, procedures, and requirements for information disclosure. It references regulatory laws and rules such as the Company Law, Securities Law, Shanghai Stock Exchange rules, and China Securities Regulatory Commission regulations. It extensively covers the preparation and disclosure of annual reports, interim reports, temporary reports, and other disclosures. The document is a regulatory or governance framework document rather than an actual financial report or announcement. It does not contain financial statements or earnings data but rather the rules and internal management for disclosures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese
内幕知情人登记管理制度（202508）
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '内幕信息知情人登记管理制度' (Insider Information Insider Registration Management System) for Hangzhou Anxu Biotechnology Co., Ltd., revised in August 2025. It outlines the management, confidentiality, and registration procedures for insiders who have access to material non-public information. The content focuses on compliance with securities laws, insider information handling, confidentiality obligations, and internal controls to prevent insider trading. There are no financial statements, earnings data, or report disclosures. It is a governance-related document detailing internal rules and procedures for managing insider information and compliance with regulatory requirements. Therefore, it fits best under Governance Information (CGR). The document length (7329 characters) and detailed procedural content support this classification with high confidence.
2025-08-06 Chinese
独立董事候选人声明与承诺（宋达峰）
Governance Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a listed company on the Science and Technology Innovation Board (科创板). It details the candidate's qualifications, compliance with regulatory requirements, and commitments to independence and legal adherence. There is no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filing of a financial nature. The document is a formal statement related to governance and compliance, specifically about the qualifications and commitments of an independent director candidate. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including director qualifications and declarations.
2025-08-06 Chinese
董事会提名委员会工作细则（202508）
Governance Information Classification · 95% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, procedures, and rules governing the nomination committee of the board of directors. It includes sections on the committee's composition, duties related to nominating directors and senior management, meeting procedures, and confidentiality obligations. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal rules document about board and management nomination processes. Therefore, it fits best under Governance Information (CGR). The document length is 2673 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication notice.
2025-08-06 Chinese
独立董事专门会议制度（202508）
Governance Information Classification · 100% confidence The document is titled '独立董事专门会议制度' which translates to 'Independent Directors Special Meeting System'. It details the rules, procedures, responsibilities, and governance structure related to independent directors' meetings within the company. It references company law, securities law, and internal governance documents. The content is about governance practices and internal rules rather than financial results, audit opinions, or announcements. It does not contain financial data or results, nor is it an announcement of a report. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.